These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 23302792)

  • 1. New antibiotic agents in the pipeline and how they can help overcome microbial resistance.
    Gould IM; Bal AM
    Virulence; 2013 Feb; 4(2):185-91. PubMed ID: 23302792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The race for antimicrobials in the multidrug resistance era.
    Molina-Santiago C; de Vicente A; Romero D
    Microb Biotechnol; 2018 Nov; 11(6):976-978. PubMed ID: 29205906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial Resistance in ESKAPE Pathogens.
    De Oliveira DMP; Forde BM; Kidd TJ; Harris PNA; Schembri MA; Beatson SA; Paterson DL; Walker MJ
    Clin Microbiol Rev; 2020 Jun; 33(3):. PubMed ID: 32404435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tackling Threats and Future Problems of Multidrug-Resistant Bacteria.
    Medina E; Pieper DH
    Curr Top Microbiol Immunol; 2016; 398():3-33. PubMed ID: 27406189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Better living through chemistry: Addressing emerging antibiotic resistance.
    Coussens NP; Molinaro AL; Culbertson KJ; Peryea T; Zahoránszky-Köhalmi G; Hall MD; Daines DA
    Exp Biol Med (Maywood); 2018 Mar; 243(6):538-553. PubMed ID: 29409348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Antibacterial Activity of Metal Complexes Containing 1,10- phenanthroline: Potential as Alternative Therapeutics in the Era of Antibiotic Resistance.
    Viganor L; Howe O; McCarron P; McCann M; Devereux M
    Curr Top Med Chem; 2017; 17(11):1280-1302. PubMed ID: 27697043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in the Fight Against Multidrug-Resistant Bacteria 2005-2016: Modern Noninferiority Trial Designs Enable Antibiotic Development in Advance of Epidemic Bacterial Resistance.
    Rex JH; Talbot GH; Goldberger MJ; Eisenstein BI; Echols RM; Tomayko JF; Dudley MN; Dane A
    Clin Infect Dis; 2017 Jul; 65(1):141-146. PubMed ID: 29017263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The global need for effective antibiotics: challenges and recent advances.
    Högberg LD; Heddini A; Cars O
    Trends Pharmacol Sci; 2010 Nov; 31(11):509-15. PubMed ID: 20843562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late stage antibacterial drugs in the clinical pipeline.
    Projan SJ; Bradford PA
    Curr Opin Microbiol; 2007 Oct; 10(5):441-6. PubMed ID: 17950658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antibiotic R&D pipeline: an update.
    Jabes D
    Curr Opin Microbiol; 2011 Oct; 14(5):564-9. PubMed ID: 21873107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies to Overcome Antimicrobial Resistance (AMR) Making Use of Non-Essential Target Inhibitors: A Review.
    Annunziato G
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31766441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The small-molecule antibiotics pipeline: 2014-2018.
    Lepore C; Silver L; Theuretzbacher U; Thomas J; Visi D
    Nat Rev Drug Discov; 2019 Sep; 18(10):739. PubMed ID: 31570838
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of vaccines on antimicrobial resistance.
    Buchy P; Ascioglu S; Buisson Y; Datta S; Nissen M; Tambyah PA; Vong S
    Int J Infect Dis; 2020 Jan; 90():188-196. PubMed ID: 31622674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What's new on the antimicrobial horizon?
    Song JH
    Int J Antimicrob Agents; 2008 Dec; 32 Suppl 4():S207-13. PubMed ID: 19134521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of Antimicrobial Resistance (AMR) and Alternative Approaches to Overcome AMR.
    Moo CL; Yang SK; Yusoff K; Ajat M; Thomas W; Abushelaibi A; Lim SH; Lai KS
    Curr Drug Discov Technol; 2020; 17(4):430-447. PubMed ID: 30836923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defeating Antibiotic-Resistant Bacteria: Exploring Alternative Therapies for a Post-Antibiotic Era.
    Wang CH; Hsieh YH; Powers ZM; Kao CY
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32033477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sources of novel antibiotics--aside the common roads.
    Donadio S; Maffioli S; Monciardini P; Sosio M; Jabes D
    Appl Microbiol Biotechnol; 2010 Dec; 88(6):1261-7. PubMed ID: 20865256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antibiotic resistance crisis, with a focus on the United States.
    Martens E; Demain AL
    J Antibiot (Tokyo); 2017 May; 70(5):520-526. PubMed ID: 28246379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing of Anticancer Drugs for the Treatment of Bacterial Infections.
    Soo VW; Kwan BW; Quezada H; Castillo-Juárez I; Pérez-Eretza B; García-Contreras SJ; Martínez-Vázquez M; Wood TK; García-Contreras R
    Curr Top Med Chem; 2017; 17(10):1157-1176. PubMed ID: 27697046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotics: past, present and future.
    Hutchings MI; Truman AW; Wilkinson B
    Curr Opin Microbiol; 2019 Oct; 51():72-80. PubMed ID: 31733401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.